Current Treatment Options in Oncology

Papers
(The H4-Index of Current Treatment Options in Oncology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Role of Metastasis-Directed Therapy in Genitourinary Cancers178
Antibody-Drug Conjugates for Melanoma and Other Skin Malignancies122
Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma91
Correction to: Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead78
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect61
Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes61
Whole Abdominal Radiotherapy in Bone and Soft Tissue Sarcomas: Indications, Techniques, Clinical Outcomes, and Future Directions56
An Update on Temporal Bone Paragangliomas55
Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer54
Clinical Application of Artificial Intelligence for Non-melanoma Skin Cancer53
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia46
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?44
Options and Considerations in the Management of Peritoneal Disease in Patients with Small Bowel Neuroendocrine Tumors43
Management of Fatigue in Patients with Advanced Cancer43
Recent Advances in Liver Transplantation for Hepatocellular Carcinoma40
Approach to Localized Squamous Cell Cancer of the Esophagus36
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers36
The Role of Nursing in the Delivery of Cardio-Oncology35
Small Cell Lung Cancer—An Update on Chemotherapy Resistance35
The Review of Modified Intersphincteric Resection in the Treatment of Ultra-Low Rectal Cancer34
Advances in Targeted Therapy for Metastatic Prostate Cancer34
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities32
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer31
Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements31
Revolutionizing Breast Cancer Therapeutics: Intersecting Frontiers of Precision Medicine, Nanotechnology, and Drug Delivery Innovations30
Regorafenib for the Treatment of Sarcoma30
Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs29
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia28
0.043087959289551